Nasal Drug Delivery Market Research Report Information by Drug Type (Anesthetics, Antibiotics), Dosage Form (Drops, Sprays), Basis of System (Unit Dose, Multi-Dose), Delivery Technologies (Spray, Nebulizers), Therapeutic Applications (Rhinitis, Asthma) End User (Home Care Settings) and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Nasal Drug Delivery Market, by Drug Type

6.1 Overview

6.2 Anesthetics

6.3 Antibiotics

6.4 Pain Relief Drugs

6.5 Calcium Supplements

6.6 Vasoconstrictors

6.7 Antihistamines

6.8 Others

Chapter 7. Global Nasal Drug Delivery Market, by Dosage Form

7.1 Overview

7.2 Drops

7.3 Sprays

7.4 Powder

7.5 Gels and Ointments

Chapter 8. Global Nasal Drug Delivery Market, by Basis of System

8.1 Overview

8.2 Unit Dose

8.3 Multi-Dose

8.4 Metered Dose

Chapter 9. Global Nasal Drug Delivery Market, by Delivery Technologies

9.1 Overview

9.2 Spray

9.3 Nebulizers

9.4 Inhalers

9.5 Others

Chapter 10. Global Nasal Drug Delivery Market, by Therapeutic Applications

10.1 Overview

10.2 Rhinitis

10.3 Asthma

10.4 Nasal Congestion

10.5 Chronic Obstructive Pulmonary Disease (COPD)

10.6 Cystic Fibrosis

10.7 Others

Chapter 11. Global Nasal Drug Delivery Market, by End Users

11.1 Overview

11.2 Home Care Settings

11.3 Hospitals & Clinics

Chapter 12. Global Nasal Drug Delivery Market, by Region

12.1 Overview

12.2 America

12.2.1 North America

12.2.1.1 US

12.2.1.2 Canada

12.2.2 Latin America

12.3 Europe

12.3.1 Western Europe

12.3.1.1 Germany

12.3.1.2 France

12.3.1.3 Italy

12.3.1.4 Spain

12.3.1.5 UK

12.3.1.6 Rest of Western Europe

12.3.2 Eastern Europe

12.4 Asia-Pacific

12.4.1 Japan

12.4.2 China

12.4.3 India

12.4.4 Australia

12.4.5 South Korea

12.4.6 Rest of Asia-Pacific

12.5 Middle East & Africa

12.5.1 Middle East

12.5.2 Africa

Chapter 13. Company Landscape

13.1 Overview

13.2 Market Share Analysis

13.3 Key Development & Strategies

13.3.1 Key Developments

Chapter 14 Company Profiles

14.1 GlaxoSmithKline Plc.

14.1.1 Company Overview

14.1.2 Type Overview

14.1.3 Financials

14.2.4 Key Developments

14.1.5 SWOT Analysis

14.2 AstraZeneca

14.2.1 Company Overview

14.2.2 Type Overview

14.2.3 Financial Overview

14.2.4 Key Developments

14.2.5 SWOT Analysis

14.3 Pfizer, Inc.

14.3.1 Company Overview

14.3.2 Type Overview

14.3.3 Financial Overview

14.3.4 Key Development

14.3.5 SWOT Analysis

14.4 Becton Dickson & Company

14.4.1 Company Overview

14.4.2 Type/Business Segment Overview

14.4.3 Financial Overview

14.4.4 Key Development

14.4.5 SWOT Analysis

14.5 Promius Pharma

14.5.1 Company Overview

14.5.2 Type Overview

14.5.3 Financial overview

14.5.4 Key Developments

14.5.5 SWOT Analysis

14.6 Sanofi-Aventis

14.6.1 Company Overview

14.6.2 Type Overview

14.6.3 Financial Overview

14.6.4 Key Developments

14.6.5 SWOT Analysis

14.7 Merck & Co.

14.7.1 Overview

14.7.2 Type Overview

14.7.3 Financials

14.7.4 Key Developments

14.7.5 SWOT Analysis

14.8 Cadila Pharmaceuticals

14.8.1 Overview

14.8.2 Type Overview

14.8.3 Financials

14.8.4 Key Developments

14.8.5 SWOT Analysis

14.9 AEGIS THERAPEUTICS LLC

14.9.1 Overview

14.9.2 Type Overview

14.9.3 Financials

14.9.4 Key Developments

14.9.5 SWOT Analysis

14.14 Novartis AG

14.14.1 Overview

14.14.2 Type Overview

14.14.3 Financials

14.14.4 Key Developments

14.14.5 SWOT Analysis

14.11 Johnson & Johnson Services, Inc.

14.11.1 Overview

14.11.2 Type Overview

14.11.3 Financials

14.11.4 Key Developments

14.11.5 SWOT Analysis

14.12 3M COMPANY

14.12.1 Overview

14.12.2 Type Overview

14.12.3 Financials

14.12.4 Key Developments

14.12.5 SWOT Analysis

14.13 Others

Chapter 15 Appendix

LIST OF TABLES

Table 1 Global Nasal Drug Delivery Market Industry Synopsis, 2020-2027

Table 2 Global Nasal Drug Delivery Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Nasal Drug Delivery Market, by Region, 2020-2027, (USD Million)

Table 4 Global Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 5 Global Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 6 Global Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 7 Global Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 8 Global Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 9 Global Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 10 North America: Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 11 North America: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 12 North America: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 13 North America: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 14 North America: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 15 North America: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 16 US: Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 17 US: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 18 US: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 19 US: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 20 US: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 21 US: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 22 Canada: Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 23 Canada: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 24 Canada: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 25 Canada: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 26 Canada: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 27 Canada: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 28 Latin America: Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 29 Latin America: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 30 Latin America: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 31 Latin America: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 32 Latin America: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 33 Latin America: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 34 Europe: Nasal Drug Delivery Market, Drug Type, 2020-2027, (USD Million)

Table 35 Europe: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 36 Europe: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 37 Europe: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 38 Europe: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 39 Europe: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 40 Western Europe: Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 41 Western Europe: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 42 Western Europe: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 43 Western Europe: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 44 Western Europe: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 45 Western Europe: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 46 Western Europe: Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 47 Eastern Europe: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 48 Eastern Europe: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 49 Eastern Europe: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 50 Eastern Europe: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 51 Eastern Europe: Nasal Drug Delivery Market, by Patent Type, 2020-2027, (USD Million)

Table 52 Eastern Europe: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 53 Asia-Pacific: Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 54 Asia-Pacific: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 55 Asia-Pacific: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 56 Asia-Pacific: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 57 Asia-Pacific: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 58 Asia-Pacific: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

Table 59 Middle East & Africa: Nasal Drug Delivery Market, by Drug Type, 2020-2027, (USD Million)

Table 60 Middle East & Africa: Nasal Drug Delivery Market, by Dosage Form, 2020-2027, (USD Million)

Table 61 Middle East & Africa: Nasal Drug Delivery Market, by Basis of System, 2020-2027, (USD Million)

Table 62 Middle East & Africa: Nasal Drug Delivery Market, by Delivery Technologies, 2020-2027, (USD Million)

Table 63 Middle East & Africa: Nasal Drug Delivery Market, by Therapeutic Applications, 2020-2027, (USD Million)

Table 64 Middle East & Africa: Nasal Drug Delivery Market, by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Application

Figure 2 Market Structure of the Global Nasal Drug Delivery Market

Figure 3 Market Dynamics of the Global Nasal Drug Delivery Market

Figure 4 Global Nasal Drug Delivery Market Share, by Drug Type 2020

Figure 5 Global Nasal Drug Delivery Market Share, by Dosage Form 2020

Figure 6 Global Nasal Drug Delivery Market Share, by Basis of System 2020

Figure 7 Global Nasal Drug Delivery Market Share, by Delivery Technologies 2020

Figure 8 Global Nasal Drug Delivery Market Share, by Therapeutic Applications 2020

Figure 9 Global Nasal Drug Delivery Market Share, by End Users, 2020

Figure 10 Global Nasal Drug Delivery Market Share, by Region, 2020

Figure 11 North America Nasal Drug Delivery Market Share, by Country, 2020

Figure 12 Europe Prescribed Health Apps Share, by Country, 2020

Figure 13 Asia-Pacific Nasal Drug Delivery Market Share, by Country, 2020

Figure 14 Middle East & Africa Nasal Drug Delivery Market Share, by Country, 2020

Figure 15 Global Nasal Drug Delivery Market: Company Share Analysis, 2020 (%)

Figure 16 GlaxoSmithKline Plc.: Key Financials

Figure 17 GlaxoSmithKline Plc.: Segmental Revenue

Figure 18 GlaxoSmithKline Plc.: Geographical Revenue

Figure 19 AstraZeneca: Key Financials

Figure 20 AstraZeneca: Segmental Revenue

Figure 21 AstraZeneca: Geographical Revenue

Figure 22 Pfizer, Inc.: Key Financials

Figure 23 Pfizer, Inc.: Segmental Revenue

Figure 24 Pfizer, Inc.: Geographical Revenue

Figure 25 Becton Dickson & Company: Key Financials

Figure 26 Becton Dickson & Company: Segmental Revenue

Figure 27 Becton Dickson & Company: Geographical Revenue

Figure 28 Promius Pharma: Key Financials

Figure 29 Promius Pharma: Segmental Revenue

Figure 30 Promius Pharma: Geographical Revenue

Figure 31 Sanofi-Aventis: Key Financials

Figure 32 Sanofi-Aventis: Segmental Revenue

Figure 33 Sanofi-Aventis: Geographical Revenue

Figure 34 Merck & Co.: Key Financials

Figure 35 Merck & Co.: Segmental Revenue

Figure 36 Merck & Co.: Geographical Revenue

Figure 37 Cadila Pharmaceuticals: Key Financials

Figure 34 Cadila Pharmaceuticals: Segmental Revenue

Figure 35 Cadila Pharmaceuticals Geographical Revenue

Figure 36 AEGIS THERAPEUTICS LLC: Key Financials

Figure 37 AEGIS THERAPEUTICS LLC: Segmental Revenue

Figure 38 AEGIS THERAPEUTICS LLC: Geographical Revenue

Figure 39 Novartis AG: Key Financials

Figure 40 Novartis AG: Segmental Revenue

Figure 41 Novartis AG: Geographical Revenue

Figure 42 Johnson & Johnson Services, Inc.: Key Financials

Figure 43 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 44 Johnson & Johnson Services, Inc.: Geographical Revenue